Displaying 9251 - 9300 of 14716 results
Released Company Title Industry Topic
04 Nov 2021
14:01 CET
CELYAD ONCOLOGY Celyad Oncology to Present Updates from Allogeneic and Autologous CAR T Programs at 63rd ASH Annual Meeting and Exposition 20103010 Biotechnology Other subject
04 Nov 2021
14:01 CET
CELYAD ONCOLOGY Celyad Oncology présentera une mise à jour de ses programmes CAR T allogéniques et autologues lors du 63ème ASH Annual Meeting and Exposition 20103010 Biotechnology Other subject
04 Nov 2021
13:00 CET
MDXHEALTH MDxHealth annonce la détermination du prix de l'offre publique initiale d'ADSs aux États-Unis 20103010 Biotechnology Share introduction and issues
04 Nov 2021
13:00 CET
MDXHEALTH MDxHealth Announces Pricing of Initial Public Offering of ADSs in the United States 20103010 Biotechnology Share introduction and issues
04 Nov 2021
10:01 CET
BARCO Update Share Buyback Program 10102030 Computer Hardware Share history
04 Nov 2021
10:00 CET
BARCO Barco redesigns its organizational structure 10102030 Computer Hardware New establishment
04 Nov 2021
08:29 CET
SHURGARD 20211104 Shurgard - Third quarter 2021 results - November 4 2021 35101010 Real Estate Holding and Development Commercial results
04 Nov 2021
08:00 CET
EURONAV Euronav maakt resultaten derde kwartaal 2021 bekend 50206030 Marine Transportation Commercial results
04 Nov 2021
08:00 CET
EURONAV EURONAV ANNOUNCES THIRD QUARTER 2021 RESULTS 50206030 Marine Transportation Commercial results
03 Nov 2021
22:30 CET
NYXOAH SA Nyxoah Annonce sa Participation à la Conférence Virtuelle Stifel 2021 Healthcare 20102010 Medical Equipment Other subject
03 Nov 2021
22:30 CET
NYXOAH SA Nyxoah Announces Participation in the Stifel 2021 Virtual Healthcare Conference 20102010 Medical Equipment Other subject
03 Nov 2021
09:46 CET
EMAKINA GROUP EPAM verwerft 98.69% van de aandelen in Emakina en gaat over tot een uitkoopbod – Emakina verlaat de beurs op 30 november 2021 10101020 Consumer Digital Services Takeover bids
03 Nov 2021
09:43 CET
EMAKINA GROUP EPAM acquires 98.69% of the shares in Emakina and proceeds with a squeeze-out – Emakina will leave the stock market on 30 November 2021 10101020 Consumer Digital Services Takeover bids
03 Nov 2021
09:40 CET
EMAKINA GROUP EPAM acquiert 98.69% des actions d'Emakina et procède à une offre de reprise – Emakina quittera la bourse le 30 novembre 2021 10101020 Consumer Digital Services Takeover bids
02 Nov 2021
18:40 CET
CRESCENT REGULATED INFORMATION – INSIDER INFORMATION - Eric Van Zele provides additional funding to Crescent NV 15101010 Telecommunications Equipment Other subject
02 Nov 2021
18:39 CET
CRESCENT GEREGLEMENTEERDE INFORMATIE - VOORWETENSCHAP - Eric Van Zele verstrekt bijkomende middelen aan Crescent NV 15101010 Telecommunications Equipment Other subject
02 Nov 2021
18:05 CET
GBL GBL - Transacties op GBL-aandelen 02-11-2021 30202000 Diversified Financial Services Other financial transaction
02 Nov 2021
18:03 CET
GBL GBL - Transactions sur actions propres 02-11-2021 30202000 Diversified Financial Services Other financial transaction
02 Nov 2021
18:02 CET
GBL GBL - Transactions on GBL shares 02-11-2021 30202000 Diversified Financial Services Other financial transaction
02 Nov 2021
17:45 CET
GIMV Gimv creates a strong national player for underground infrastructure through the strategic combination of Baas-Verkley 30202010 Asset Managers and Custodians Other subject
02 Nov 2021
17:45 CET
GIMV Gimv creates a strong national player for underground infrastructure through the strategic combination of Baas-Verkley 30202010 Asset Managers and Custodians Other subject
02 Nov 2021
17:45 CET
GIMV Gimv vormt sterke nationale speler voor ondergrondse infrastructuur door strategische combinatie Baas-Verkley 30202010 Asset Managers and Custodians Other subject
02 Nov 2021
17:41 CET
BEFIMMO Befimmo SA: Etat du programme de liquidité 35102030 Office REITs Other subject
02 Nov 2021
17:41 CET
BEFIMMO Befimmo NV: Update met betrekking tot het liquiditeitsprogramma 35102030 Office REITs Other subject
02 Nov 2021
17:41 CET
BEFIMMO Befimmo SA: Update regarding the liquidity contract 35102030 Office REITs Other subject
02 Nov 2021
17:40 CET
AGEAS Ageas reports on the progress of share buy-back programme 30301010 Life Insurance Other financial transaction
02 Nov 2021
17:40 CET
KBC ANCORA ord Bekendmaking van het totaal aantal stemrechten per 31 oktober 2021 30101010 Banks Other subject
02 Nov 2021
17:40 CET
KBC ANCORA ord Announcement of the total number of voting rights as at 31 October 2021 30101010 Banks Other subject
02 Nov 2021
17:40 CET
AGFA-GEVAERT Agfa-Gevaert: Share buyback program – regulated information 50202025 Electronic Equipment: Gauges and Meters Other subject
02 Nov 2021
17:40 CET
AGEAS Rapport d’Ageas sur le programme de rachat d’actions 30301010 Life Insurance Other financial transaction
02 Nov 2021
17:40 CET
KBC ANCORA ord Annonce du nombre total des droits de vote au 31 octobre 2021 30101010 Banks Other subject
02 Nov 2021
17:40 CET
AGFA-GEVAERT Agfa-Gevaert: Aandeleninkoopprogramma – gereglementeerde informatie 50202025 Electronic Equipment: Gauges and Meters Other subject
02 Nov 2021
17:40 CET
AGEAS Ageas rapporteert over de inkoop van eigen aandelen 30301010 Life Insurance Other financial transaction
02 Nov 2021
16:11 CET
MIKO MIKO ACQUIRES FELLOW COFFEE ROASTING COMPANY SAS 45101020 Soft Drinks Mergers, Acquiqitions, Transferts
02 Nov 2021
16:10 CET
MIKO MIKO REPREND LE TORREFACTEUR DE CAFE SAS 45101020 Soft Drinks Mergers, Acquiqitions, Transferts
02 Nov 2021
16:08 CET
MIKO MIKO NEEMT COLLEGA KOFFIEBRANDERIJ SAS OVER 45101020 Soft Drinks Mergers, Acquiqitions, Transferts
02 Nov 2021
08:00 CET
CELYAD ONCOLOGY Celyad Oncology annonce sa participation à une Conférences en novembre 2021 20103010 Biotechnology Other subject
02 Nov 2021
08:00 CET
CELYAD ONCOLOGY Celyad Oncology Announces November 2021 Conference Schedule 20103010 Biotechnology Other subject
02 Nov 2021
07:00 CET
HYLORIS Hyloris Announces Start of Phase 2 Study of Miconazole-Domiphen Bromide Vaginal Cream in Vulvovaginal Candidiasis   20103010 Biotechnology Other subject
02 Nov 2021
07:00 CET
HYLORIS Hyloris annonce le début de l'étude de phase 2 de Miconazole-Bromure de Domiphène, une crème vaginale dans la candidose vulvo-vaginale 20103010 Biotechnology Other subject
01 Nov 2021
18:16 CET
GBL GBL - Stemrechten en noemer - Situatie op 31 oktober 2021 30202000 Diversified Financial Services Corporate life
01 Nov 2021
18:15 CET
GBL GBL - Droits de vote et dénominateur - Situation au 31 octobre 2021 30202000 Diversified Financial Services Corporate life
01 Nov 2021
18:14 CET
GBL GBL - Voting rights and denominator - Situation as at October 31, 2021 30202000 Diversified Financial Services Corporate life
01 Nov 2021
07:00 CET
HYLORIS Hyloris annonce l'acceptation par la FDA de la demande de nouveau médicament pour Maxigesic® IV dans le traitement de la douleur post-opératoire   20103010 Biotechnology Other subject
01 Nov 2021
07:00 CET
HYLORIS Hyloris Announces FDA Acceptance of New Drug Application for Maxigesic® IV in Post-Operative Pain 20103010 Biotechnology Other subject
29 Oct 2021
22:30 CEST
NYXOAH SA Informations sur le nombre total de droits de vote et d'actions 20102010 Medical Equipment Other subject
29 Oct 2021
22:30 CEST
NYXOAH SA Information on the total number of voting rights and shares 20102010 Medical Equipment Other subject
29 Oct 2021
22:05 CEST
CELYAD ONCOLOGY Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007) 20103010 Biotechnology Change in Capital
29 Oct 2021
22:05 CEST
CELYAD ONCOLOGY Celyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007) 20103010 Biotechnology Change in Capital
29 Oct 2021
19:05 CEST
ECONOCOM GROUP ECONOCOM : COMMUNIQUE DE PRESSE RELATIF AU DENOMINATEUR 10101010 Computer Services Legal